Top Upgrades
- Jefferies upgraded Laboratory Corp. of America Holdings LH from Hold to Buy. Laboratory Corp shares rose 0.8 percent to $156.00 in pre-market trading.
- Wells Fargo upgraded Exelon Corporation EXC from Market Perform to Outperform. Exelon shares rose 0.8 percent to $50.25 in pre-market trading.
- Analysts at Deutsche Bank upgraded Hostess Brands Inc TWNK from Hold to Buy. Hostess Brands shares rose 3 percent to $13.10 in pre-market trading.
- Analysts at BTIG Research upgraded AtriCure Inc. ATRC from Neutral to Buy. AtriCure shares rose 2.16 percent to close at $27.37 on Monday.
- B. Riley FBR upgraded EMCORE Corporation EMKR from Hold to Buy. EMCORE shares rose 6.7 percent to $3.91 in pre-market trading.
- Jefferies upgraded Quest Diagnostics Inc DGX from Hold to Buy. Quest shares rose 1 percent to $91.01 in pre-market trading.
- Analysts at Credit Suisse upgraded Commscope Holding Company Inc COMM from Neutral to Outperform. CommScope rose 5.5 percent to $23.45 in pre-market trading.
- KeyBanc upgraded Qorvo Inc QRVO from Sector Weight to Overweight. Qorvo shares rose 1.4 percent to $74.25 in pre-market trading.
- SunTrust Robinson Humphrey upgraded Amphenol Corporation APH from Hold to Buy. Amphenol shares rose 1 percent to $98.80 in pre-market trading.
Top Downgrades
- UBS downgraded AstraZeneca plc AZN from Neutral to Sell. AstraZeneca shares fell 1.3 percent to $40.73 in pre-market trading.
- Citigroup downgraded Coty Inc COTY from Buy to Neutral. Coty shares fell 0.3 percent to $11.25 in pre-market trading.
- HSBC downgraded Ryanair Holdings plc RYAAY from Buy to Hold. Ryanair shares fell 2.8 percent to $73.00 in pre-market trading.
- DA Davidson downgraded Eagle Materials, Inc. EXP from Buy to Neutral. Eagle Materials shares fell 0.3 percent to $83.50 in pre-market trading.
- Credit Suisse downgraded Alcoa Corp AA from Outperform to Neutral. Alcoa shares closed at $29.46 on Monday.
- Guggenheim downgraded Wingstop Inc WING from Buy to Neutral. Wingstop shares fell 1.7 percent to close at $74.74 on Monday.
- Stephens & Co. downgraded Pacific Biosciences of California PACB from Overweight to Equal-Weight. Pacific Biosciences shares fell 1 percent to $7.24 in pre-market trading.
- BTIG Research downgraded Care.com Inc CRCM from Buy to Neutral. Care.com shares fell 3.4 percent to $17.83 in pre-market trading.
- Citigroup downgraded DowDuPont Inc DWDP from Buy to Neutral. DowDuPont shares fell 32.5 percent to $36.74 in pre-market trading.
Top Initiations
- Seaport Global initiated coverage on Rayonier Inc. RYN with a Neutral rating. Rayonier shares closed at $31.74 on Monday.
- Rosenblatt initiated coverage on Netflix, Inc. NFLX with a Neutral rating. The price target for Netflix is set to $350. Netflix shares closed at $366.96 on Monday.
- Analysts at Cowen & Co. initiated coverage on Teledyne Technologies Incorporated TDY with an Outperform rating. The price target for Teledyne Technologies is set to $265. Teledyne Technologies shares closed at $240.21 on Monday.
- Rosenblatt initiated coverage on Walt Disney Co DIS with a Buy rating. Disney closed at $112.51 on Monday.
- Analysts at Cross Research initiated coverage on LYFT Inc LYFT with a Buy rating. LYFT shares closed at $69.01 on Monday.
- Deutsche Bank initiated coverage on Intuitive Surgical, Inc. ISRG with a Buy rating. The price target for Intuitive Surgical is set to $630. Intuitive Surgical shares closed at $575.54 on Monday.
- Analysts at Barclays initiated coverage on Anheuser Busch Inbev NV BUD with an Equal-Weight rating. Anheuser Busch Inbev shares closed at $83.64 on Monday.
- William Blair initiated coverage on Q2 Holdings Inc QTWO with an Outperform rating. Q2 Holdings shares closed at $69.71 on Monday.
- DA Davidson initiated coverage on Lovesac Co LOVE with a Buy rating. The price target for Lovesac is set to $38. Lovesac shares closed at $28.41 on Monday.
- Analysts at Rosenblatt initiated coverage on Roku Inc ROKU with a Neutral rating. The price target for Roku is set to $63. Roku closed at $69.11 on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in